Advisornet Financial’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.6K | Sell |
4,081
-6,385
| -61% | -$114K | ﹤0.01% | 855 |
|
|
2025
Q1 | $187K | Buy |
10,466
+1,500
| +17% | +$26.7K | 0.01% | 560 |
|
|
2024
Q4 | $267K | Hold |
8,966
| – | – | 0.02% | 443 |
|
|
2024
Q3 | $140K | Buy |
8,966
+966
| +12% | +$15.1K | 0.01% | 608 |
|
|
2024
Q2 | $137K | Buy |
8,000
+2,500
| +45% | +$42.8K | 0.01% | 563 |
|
|
2024
Q1 | $86K | Buy |
5,500
+2,500
| +83% | +$39.1K | 0.01% | 670 |
|
|
2023
Q4 | $44.8K | Hold |
3,000
| – | – | ﹤0.01% | 835 |
|
|
2023
Q3 | $48.5K | Hold |
3,000
| – | – | ﹤0.01% | 796 |
|
|
2023
Q2 | $125K | Buy |
3,000
+800
| +36% | +$33.2K | 0.01% | 589 |
|
|
2023
Q1 | $132K | Sell |
2,200
-10
| -0.5% | -$601 | 0.01% | 558 |
|
|
2022
Q4 | $162K | Buy |
2,210
+400
| +22% | +$29.3K | 0.02% | 512 |
|
|
2022
Q3 | $138K | Hold |
1,810
| – | – | 0.01% | 578 |
|
|
2022
Q2 | $126K | Buy |
1,810
+10
| +0.6% | +$696 | 0.01% | 603 |
|
|
2022
Q1 | $149K | Sell |
1,800
-5
| -0.3% | -$414 | 0.01% | 626 |
|
|
2021
Q4 | $136K | Buy |
1,805
+484
| +37% | +$36.5K | 0.01% | 692 |
|
|
2021
Q3 | $153K | Hold |
1,321
| – | – | 0.01% | 661 |
|
|
2021
Q2 | $293K | Hold |
1,321
| – | – | 0.02% | 483 |
|
|
2021
Q1 | $175K | Hold |
1,321
| – | – | 0.01% | 591 |
|
|
2020
Q4 | $229K | Buy |
1,321
+6
| +0.5% | +$1.04K | 0.02% | 467 |
|
|
2020
Q3 | $146K | Hold |
1,315
| – | – | 0.01% | 570 |
|
|
2020
Q2 | $78K | Buy |
1,315
+1,250
| +1,923% | +$74.1K | 0.01% | 739 |
|
|
2020
Q1 | $4K | Hold |
65
| – | – | ﹤0.01% | 1472 |
|
|
2019
Q4 | $5K | Buy |
+65
| New | +$5K | ﹤0.01% | 1544 |
|